Direct answer
No supplement is a proven routine treatment or cure for eczema. Vitamin D trials are mixed, omega-3 studies are small, and routine probiotics have not shown a meaningful benefit. Correct documented nutrient deficiencies for nutritional reasons, and keep moisturizers and prescribed anti-inflammatory treatment as the foundation.
- No supplement cures eczema — vitamin D and omega-3 studies have mixed or preliminary signals, while probiotics are not supported as routine treatment; any supplement considered is an adjunct to moisturizers and prescribed anti-inflammatory treatment.
- Vitamin D evidence conflicts: a 2024 meta-analysis of 11 RCTs (686 participants) found a modest severity reduction (SMD −0.41), while a 2023 meta-analysis of 5 RCTs found no general effect — and two authors of the positive study disclosed dermatology/pharma relationships.
- A small pediatric EPA trial (48 children) reported improvement over 4 weeks, but its SCORAD numbers differ between the abstract and results table. It declared no specific grant or financial conflicts; capsule purchase or donation terms were not reported, but Cochrane’s broader dietary-supplement review found no convincing evidence overall and called fish-oil data small-study and modest.
- Cochrane reviewed 39 RCTs (2,599 participants) and concluded probiotics "probably make little or no difference" to eczema symptoms — notably, 10 of the included trials were funded by probiotic suppliers, yet the result was still null.
- Evening primrose oil and borage oil showed no demonstrated eczema benefit in the cited review: a 27-study Cochrane review (1,596 participants) found no statistically significant advantage over placebo for either oil.
Ingredient evidence · Eczema · Supplement claims
No supplement cures eczema. Vitamin D and omega-3 EPA/DHA studies offer mixed or preliminary signals. Correcting documented vitamin D deficiency has a nutritional rationale, but is not proven to identify the people whose eczema will respond. Adult probiotic findings are preliminary; routine probiotics, evening primrose oil, borage oil, “eczema cure” blends, homeopathy, essential oils, detoxes, and overhyped black seed oil do not have strong clinical evidence for routine eczema treatment (Cochrane dietary supplements review, Cochrane probiotics review, Cochrane evening primrose/borage review, AAD food guidance).
Table of contents
- Evidence summary
- Answer-first verdict
- All supplement forms and claim types
- Proven vs popular: verdict table
- What has the best evidence
- Popular eczema supplements with weak or no evidence
- Mechanisms: why claims sound plausible
- Reported risks and side effects
- Interaction and safety checks
- Who should avoid eczema supplements
- FAQ
- Sources
Evidence summary
| Claim | Evidence | Funding / conflict trace | Independence rating | Strength |
|---|---|---|---|---|
| Vitamin D improves eczema severity. | 2024 meta-analysis: 11 RCTs, 686 participants; vitamin D reduced AD severity versus control (SMD −0.41, 95% CI −0.67 to −0.16). 2023 meta-analysis: 5 RCTs, 304 cases; no significant general effect. | 2024 review reported no external funding but disclosed pharma relationships for two authors; 2023 review had Korean public funding and declared no conflicts. | Mixed: one partly conflicted, one public-funded. | MIXED / targeted 2024 review / 2023 review |
| Omega-3 EPA/DHA helps eczema. | Pediatric EPA RCT: 48 enrolled, 43 completed; authors reported SCORAD improvement and reduced steroid readministration at week 4; SCORAD figures are inconsistent between the abstract and results table. A 2024 product-combination RCT also improved SCORAD but used EPA+DHA+GLA+vitamin D, so the active ingredient cannot be isolated. | EPA RCT reported no specific public/commercial/not-for-profit grant and no conflicts; 2024 combination RCT had cash funding and active/placebo product supply from 4U Pharma, with authors declaring no conflicts. | EPA financing was declared grant-free, but capsule purchase/donation terms were not reported; the small trial has reporting inconsistencies. Combination trial had company cash and product support. | PROMISING / not proven as routine EPA RCT / Combination RCT |
| Probiotics treat established eczema. | Cochrane: 39 RCTs, 2,599 participants; probiotics probably make little or no difference in patient-rated eczema symptoms. | 10 included studies were supplier-funded and 4 did not declare funding. Review support included public institutions and NIHR; several review authors disclosed dairy/probiotic or pharmaceutical relationships. | Full review disclosures were read: Boyle and Tang reported Danone/Nutricia/Nestlé or other industry ties; Tang also reported Prota Therapeutics employment and shares/options. Trial sponsorship and methods varied. (Primary source) | DOESN’T routinely Cochrane |
| Probiotics prevent eczema. | NCCIH cites a 2015 review of 17 studies with 4,755 participants where pregnancy/early-infancy probiotic exposure lowered atopic dermatitis risk, especially with mixtures; AAD still recommends against probiotic supplementation for pediatric AD prevention. | NCCIH is a public-health source and says product mentions are not endorsements; AAD guideline page does not state funding/conflicts. | Full review/guideline funding/COI not verified; underlying study sponsorship and methods vary. (Primary source) | MIXED / not routine NCCIH / AAD |
| Evening primrose oil or borage oil helps eczema. | Cochrane: 27 studies, 1,596 adults and children; no statistically significant advantage over placebo. | The review listed Cathy Bennett as internal support and no external support. Bamford disclosed an Efamol-repaid trial grant and Efamol medication, placebo and blood-test support. | Author involvement in a company-supported included trial was disclosed; another reviewer assessed that trial. Eleven of the 27 studies were unpublished pharmaceutical-house studies. (Primary source) | DOESN’T Cochrane |
| Homeopathy helps eczema. | Systematic review found only 3 controlled trials, all methodologically weak, and none demonstrated efficacy. | Original review reported no funding sources and no conflicts declared. One randomized and two nonrandomized studies were small or methodologically weak. | Review-level disclosures verified in the original free full text; underlying trial financing was not completely traced. (Primary source) | DOESN’T PubMed / NCCIH |
| Black seed oil helps eczema. | 2022 review included small heterogeneous skin-disease trials, including atopic dermatitis/eczema studies, but noted limited standardization, limited sample size, no PROSPERO preregistration, and broad skin-disorder pooling. | Funding not stated in page content; authors declared no conflicts. | Funding was not reported; no conflicts were declared. Independence remains unverified, and the mixed study designs and pooled skin conditions limit eczema-specific inference. | OVERHYPED / insufficient PMC review |
| Detoxes and cleanses help eczema. | NCCIH reports no compelling evidence for detox diets eliminating toxins and no long-term evidence; no eczema-specific benefit is established. | NCCIH public-health source; no product endorsement. | NIH public-health guidance; no product endorsement. This does not establish the independence of every underlying study. | DOESN’T NCCIH |
Answer-first verdict
If a person with eczema wants to try a supplement, the most defensible starting questions are: is vitamin D deficiency plausible or documented, is omega-3 intake low, and is there a clear indication beyond an unproven eczema claim, and would a live probiotic product be safe for this person? Vitamin D and omega-3 studies have mixed or preliminary results, while probiotics are not evidence-based routine treatment for established eczema, and evening primrose oil, borage oil, homeopathy, detoxes, and cure blends should be treated as unsupported claims (Cochrane dietary supplements review, Cochrane probiotics review, Cochrane evening primrose/borage review).
Text version of this infographic
Vitamin D studies are mixed, omega-3 EPA/DHA findings come from small trials, and probiotic treatment has not shown a meaningful routine benefit. Deficiency correction is a separate nutritional indication. Weak, unsupported, or overhyped options: evening primrose oil, borage oil, homeopathy, “eczema cure” blends, essential oils applied to eczema, detoxes, and black seed oil hype. None replace moisturizers or anti-inflammatory flare treatment.
All supplement forms and claim types
| Ingredient / form | What it is | Claimed use | Evidence grade | Bottom line |
|---|---|---|---|---|
| Vitamin D3 / cholecalciferol | Common supplement form; animal-derived or lichen-derived. | Correct nutritional deficiency; proposed eczema benefit remains uncertain. | Mixed RCT meta-analysis evidence. | Most rational when deficiency correction is indicated; avoid megadoses. NIH ODS |
| Vitamin D2 / ergocalciferol | Yeast/fungal-derived vitamin D form. | Same as D3. | No eczema-specific superiority evidence. | Can raise vitamin D status, but neither D2-specific efficacy nor preferential eczema response to deficiency correction is established. NIH ODS |
| Calcifediol / 25(OH)D3 | Pre-hydroxylated vitamin D metabolite used in some studies/medical contexts. | Faster status correction. | Not eczema-first evidence. | Medicalized form; not a casual eczema supplement. NIH ODS |
| Fish oil EPA/DHA | Long-chain omega-3 from fish oil. | Lower inflammatory signaling and itch. | Promising but small and mixed. | The cited small trial tested EPA; it does not establish DHA or a generic “omega” blend as an effective eczema therapy. EPA RCT |
| Algal EPA/DHA | Non-fish long-chain omega-3 source. | Same active long-chain omega-3 claim. | No eczema-specific superiority evidence. | Biologically plausible alternative to fish-derived EPA/DHA; eczema outcomes not well proven. |
| Flax/chia ALA | Plant omega-3 precursor. | “Plant omega-3 for eczema.” | Weak for eczema treatment. | Healthy food fat, but not equivalent to direct EPA/DHA because conversion is limited. NIH ODS |
| Probiotic capsules/powders | Live microorganisms, usually Lactobacillus, Bifidobacterium, or mixtures. | Modulate gut-skin immune axis. | Cochrane negative for routine treatment. | Strain, dose, timing, age, and immune status matter; do not generalize. Cochrane |
| Probiotic foods | Fermented foods with live cultures depending on product. | “Natural probiotic eczema support.” | Insufficient as eczema treatment. | Food preference may be fine; not a treatment substitute. |
| Evening primrose oil | Gamma-linolenic acid oil. | Correct fatty-acid imbalance. | Cochrane negative. | Do not recommend for eczema. Cochrane |
| Borage oil | High-GLA seed oil. | Same GLA eczema claim. | Cochrane negative. | Not an evidence-based eczema treatment. Cochrane |
| Essential oils | Concentrated volatile plant oils used topically or aromatically. | “Natural anti-inflammatory/antimicrobial eczema remedy.” | Insufficient and safety-limited. | Can irritate or sensitize eczema-prone skin; tea tree oil should not be swallowed. NCCIH |
| Homeopathic eczema remedies | Highly diluted or sometimes non-dilute preparations based on homeopathy principles. | Individualized eczema cure/support. | Negative/insufficient. | Not evidence-based; some products may contain active ingredients or contaminants. NCCIH |
| Detoxes/cleanses | Fasting, juices, laxatives, herbs, teas, colon-cleansing programs. | Remove “toxins” causing eczema. | No eczema evidence. | Can cause dehydration, electrolyte imbalance, GI harm, and nutrient shortfall. NCCIH |
| Black seed oil / Nigella sativa | Seed oil/extract containing thymoquinone and other compounds. | Anti-inflammatory skin support. | Insufficient eczema-specific evidence. | Interesting but overhyped; standardization and sample-size issues are major limitations. PMC review |
Proven vs popular: verdict table
| Supplement claim | Verdict | Evidence | Use-case if any | Main caveat |
|---|---|---|---|---|
| Vitamin D for eczema severity | MIXED / no routine proof | 2024 meta-analysis positive; 2023 meta-analysis not generally positive. | Correct documented deficiency for nutritional reasons under clinician guidance; eczema benefit remains uncertain. | Do not megadose; toxicity is real. NIH ODS |
| Omega-3 EPA/DHA for eczema | PROMISING / not proven routine | Small EPA RCT reported benefit but has inconsistent SCORAD figures; Cochrane says supplement evidence is not convincing overall. | Discuss if dietary intake is low or there are non-eczema reasons to optimize omega-3. | Medication review is appropriate; high-dose trials found an atrial-fibrillation signal, while clinically significant bleeding was generally not increased. NIH ODS |
| Specific probiotics for selected people | LIMITED / strain-specific | Cochrane negative for routine treatment; NCCIH notes preliminary adult signals and mixed prevention data. | No routine eczema recommendation; preliminary adult findings do not identify a proven product. Check live-microbe safety before any use. | Live microbe risk in high-risk groups. NCCIH |
| Evening primrose oil | DOESN'T | 27-study Cochrane review negative. | No evidence-based eczema role. | Bleeding/GI cautions. Cochrane |
| Borage oil | DOESN'T | Cochrane review negative. | No evidence-based eczema role. | Product quality and GI/safety concerns. |
| Homeopathic eczema remedies | DOESN'T | Systematic review found no efficacy in weak controlled trials. | None as eczema treatment. | Risk of delaying effective care. PubMed |
| Essential oils for eczema rash | AVOID on active eczema unless clinician-directed | No strong eczema RCT evidence; topical oils can irritate. | Not a treatment default. | Concentrated fragrances can worsen dermatitis; tea tree oil is toxic if swallowed. NCCIH |
| Detox for eczema | DOESN'T | No compelling detox evidence for toxin elimination and no eczema-specific support. | None. | Dehydration, electrolyte imbalance, malnutrition risk. NCCIH |
| Black seed oil | INSUFFICIENT / overhyped | Small heterogeneous studies; standardization and protocol limitations. | Not routine eczema therapy. | GI irritation and topical reactions reported. PMC review |
What has the best evidence
Vitamin D: useful when it corrects a real problem
Vitamin D studies show mixed results; the cited reviews do not establish it as the best eczema supplement. The 2024 systematic review found a statistically significant but modest reduction in atopic dermatitis severity across 11 RCTs and no reported treatment-related adverse effects in these short studies, which does not establish long-term safety; however, two authors disclosed multiple dermatology/pharma relationships, so the result should be interpreted conservatively (2024 vitamin D meta-analysis). A 2023 meta-analysis found vitamin D was not generally effective for atopic dermatitis and suggested any benefit may depend on geography, dose, or subgroup, with public Korean funding and no conflicts declared (2023 vitamin D meta-analysis).
Practical verdict: vitamin D is not an eczema cure, but correcting low vitamin D status may be reasonable when a clinician thinks status correction is indicated. NIH ODS notes that vitamin D toxicity is almost always due to excessive supplement intake and can cause hypercalcemia, hypercalciuria, kidney stones, renal failure, soft-tissue calcification, arrhythmias, and death in extreme cases (NIH ODS vitamin D).
Omega-3: promising, but the evidence is small and mixed
A small pediatric EPA trial provided an omega-3 eczema signal: 48 children were randomized to EPA 250 mg twice daily or placebo for four weeks, and the authors reported significant SCORAD improvements and lower topical corticosteroid readministration at week 4 (P=.047); the week-2 steroid difference was not significant. Few GI side effects were reported. However, the abstract and results table give conflicting SCORAD means and P values, so the precise size of benefit is uncertain. The study declared no specific grant and no financial conflicts; it named Epastigel (Pars Pharmed) but did not report capsule purchase or donation terms (EPA RCT). A 2024 trial in children found improvement with a product containing fish oil, EPA, DHA, GLA, and vitamin D3, but it received cash funding and active/placebo products from 4U Pharma and the multi-ingredient formula prevents attributing the result to omega-3 alone (Omega-3 combination RCT).
The 2012 Cochrane review, which predates those later trials, was more skeptical, finding no convincing evidence that dietary supplements improve established eczema and only possible modest fish-oil benefit from small studies (Cochrane dietary supplements review). Practical verdict: these small studies are insufficient for a confident EPA/DHA recommendation, but it should not be marketed as proven routine eczema treatment.
Probiotics: strain-specific possibility, routine-treatment failure
Probiotics are plausible because eczema involves immune signaling and barrier biology, but plausibility has not translated into reliable treatment benefit. Cochrane reviewed 39 RCTs with 2,599 participants and concluded that currently available probiotic strains probably make little or no difference in patient-rated eczema symptoms, with 10 included studies funded by probiotic suppliers and 4 not declaring funding (Cochrane probiotics review).
NCCIH gives a nuanced picture: a 2017 review of 13 pediatric studies did not find consistent benefit for treatment, a 9-study adult review found preliminary evidence for some strains, and a 2015 review of 17 studies suggested pregnancy or early-infancy probiotic exposure lowered atopic dermatitis risk, especially with mixtures (NCCIH probiotics). AAD still conditionally recommends against probiotic supplementation for pediatric atopic dermatitis prevention, which means the prevention signal is not strong enough for routine public-health use (AAD guideline).
Text version of this infographic
Vitamin D has mixed meta-analyses; deficiency correction has a separate nutritional rationale. EPA/DHA has small preliminary trials, with reporting and sponsorship limitations. Cochrane does not support routine probiotics for eczema, and preliminary adult findings do not identify a proven strain or product. Safety and medication checks come before use.
Popular eczema supplements with weak or no evidence
Evening primrose oil and borage oil: plausible mechanism, negative trials
Evening primrose oil and borage oil are popular because they contain gamma-linolenic acid, but Cochrane reviewed 27 studies in 1,596 adults and children and found no statistically significant advantage over placebo for either oil (Cochrane evening primrose/borage review). NCCIH also states that oral evening primrose oil has not been shown to relieve atopic dermatitis symptoms and that the evidence is not sufficient to support evening primrose oil for any health condition (NCCIH evening primrose oil).
“Eczema cure” supplement blends: evidence laundering risk
Multi-ingredient eczema blends often combine omega-3, GLA, probiotics, vitamin D, zinc, quercetin, turmeric, collagen, or herbs, then cite research on one ingredient as if it proves the entire blend. That is not valid because Cochrane’s dietary-supplement review found no convincing evidence for dietary supplements overall, and a positive multi-ingredient trial cannot identify which ingredient caused the effect (Cochrane dietary supplements review, Omega-3 combination RCT).
Homeopathic eczema remedies: no credible efficacy signal
A systematic review of homeopathy for eczema found only three controlled clinical trials, all methodologically weak, and none demonstrated efficacy (PubMed homeopathy review). NCCIH states there is little evidence to support homeopathy as effective for any specific health condition and warns that some products labeled homeopathic may contain substantial active ingredients that can cause side effects or drug interactions (NCCIH homeopathy).
Essential oils: “natural” does not mean eczema-safe
Essential oils are concentrated fragrance chemicals, and eczema-prone skin is already vulnerable to irritants and allergens. NCCIH says topical tea tree oil may cause redness or irritation in some people and should not be swallowed because oral ingestion can cause confusion, unsteadiness, inability to walk, and coma (NCCIH tea tree oil).
Detoxes and cleanses: no toxin-removal proof, real safety risks
Detox claims are especially weak for eczema because they usually do not define the toxin, prove the toxin causes the rash, or show eczema outcomes improve after removal. NCCIH reports no compelling research supporting detox diets for eliminating toxins, no long-term evidence, and safety risks including unsafe products, laxative-induced diarrhea, dehydration, electrolyte imbalance, fasting-related fainting, and high-oxalate juice concerns in kidney-stone-prone people (NCCIH detoxes and cleanses).
Black seed oil: interesting, not ready
A 2022 systematic review of Nigella sativa human skin-disease studies included small eczema/atopic dermatitis studies using topical ointment, topical lotion, or oral capsules, but the authors noted lack of herbal standardization, lack of chemical-constituent measurement, limited sample size, no PROSPERO preregistration, and broad pooling across skin disorders (Nigella sativa review). The same review reported gastrointestinal and topical reactions in some studies across different skin conditions; their frequency cannot be generalized to eczema treatment or every black-seed product, so black seed oil should not be treated as a harmless eczema cure (Nigella sativa review).
Text version of this infographic
Red flags in eczema supplement marketing include: “cures eczema from the root,” “detoxes toxins causing flare-ups,” citing cell or mouse studies as human proof, using one ingredient study to prove a multi-ingredient blend, not specifying dose/strain/standardization/conflicts, and discouraging prescribed treatment.
Mechanisms: why claims sound plausible
Vitamin D has immune and barrier plausibility, but NIH ODS emphasizes that status is assessed through serum 25(OH)D and that toxicity can occur through excess supplement use; plausibility does not justify high-dose self-treatment (NIH ODS vitamin D). Omega-3 EPA/DHA plausibly changes inflammatory lipid mediators, but NIH ODS warns that high doses can prolong bleeding time and that 4 g/day trials found slightly increased atrial fibrillation risk in high-risk groups (NIH ODS omega-3).
Probiotics sound plausible because immune tolerance and gut microbiome research are real, but live microbes are not risk-free: NCCIH notes infections, harmful substance production, antibiotic-resistance gene transfer, and severe or fatal infections in premature infants have been reported (NCCIH probiotics). Evening primrose oil and borage oil sound plausible because GLA is involved in fatty-acid metabolism, but Cochrane’s placebo-controlled evidence does not show meaningful eczema benefit (Cochrane evening primrose/borage review).
Text version of this infographic
A plausible mechanism such as immune modulation, lipid-mediator changes, or microbiome effects is not enough. A supplement claim should pass through human randomized trials with clear dose, population, and eczema outcomes before becoming a practice recommendation. Products that jump from mechanism straight to cure claim should be downgraded.
Reported risks and side effects
| Supplement / remedy | Common side effects | Serious risks and safety uncertainties | At-risk groups | Safety source |
|---|---|---|---|---|
| Vitamin D | Usually none at appropriate doses; excess may cause nausea, vomiting, weakness, pain, appetite loss, dehydration, excessive thirst, frequent urination. | Hypercalcemia, hypercalciuria, kidney stones, renal failure, soft-tissue calcification, cardiac arrhythmias, death in extreme toxicity. | Kidney disease, hyperparathyroidism, thiazide users, high calcium intake, people stacking multiple vitamin D products. | NIH ODS |
| Omega-3 EPA/DHA | Unpleasant taste, bad breath, heartburn, nausea, GI discomfort, diarrhea, headache, fishy-smelling sweat. | High doses can affect platelet function, but clinically significant bleeding was generally not increased in the research summarized by ODS; 4 g/day trials showed slightly increased atrial fibrillation risk in high-risk cardiovascular populations. | Anticoagulant/antiplatelet users, bleeding disorders, surgery, atrial fibrillation risk, fish allergy. | NIH ODS |
| Probiotics | Gastrointestinal symptoms were reported in eczema trials; their frequency and severity remain uncertain. | Infections, harmful substance production, antibiotic-resistance gene transfer, severe/fatal infections in premature infants. | Premature infants, severely ill hospital patients, immunocompromised people, other high-risk patients requiring individual medical review. | NCCIH / Cochrane full review |
| Evening primrose oil | Abdominal pain, nausea, diarrhea, upset stomach, headache. | Potential bleeding concern with anticoagulants noted in Cochrane; long-term safety not established. | Anticoagulant users, surgery, pregnancy/lactation without medical review, or complex medicines. | Cochrane / NCCIH |
| Borage oil | GI upset and diarrhea-like effects similar to GLA oil trials. | Plant parts and unverified seed oils raise pyrrolizidine-alkaloid quality concerns. LactMed advises only PA-free certified seed oils; this does not certify eczema efficacy or long-term safety. | Liver disease, pregnancy/lactation, people using multiple herbal products. | Cochrane / LactMed borage |
| Homeopathic products | Depends on dilution and ingredients; alcohol exposure with some liquid products. | Some products may contain substantial active ingredients, heavy metals, or other substances; delaying effective treatment can cause harm. | Infants, pregnancy/lactation, chronic disease, people replacing prescribed therapy. | NCCIH |
| Essential oils | Redness, irritation, burning, allergic contact dermatitis risk. | Tea tree oil ingestion can cause confusion, unsteadiness, inability to walk, and coma. | People who develop topical redness or irritation; anyone at risk of accidental ingestion. The cited tea-tree page does not establish an essential-oil class warning for pets, pregnancy or asthma. | NCCIH |
| Detoxes / cleanses | Hunger, headache, weakness, diarrhea, fainting, dehydration. | Electrolyte imbalance, malabsorption, infection from untreated juices, kidney-stone risk from high-oxalate juices, complications from colon cleansing. | Children, older adults, pregnancy/lactation, diabetes, kidney disease, heart disease, GI disease, immunocompromised people. | NCCIH |
| Black seed oil | Transient GI problems, gastric irritation, abdominal cramps, indigestion, topical reactions. | Serious human-risk frequency is not established. The cited keratinocyte cytotoxicity finding is laboratory evidence, not a demonstrated rare clinical adverse effect. | Safety cannot be generalized across ages, conditions, oral products or topical preparations; individual medical review is needed. | Nigella sativa review |
Interaction and safety checks
| Supplement / remedy | Interacts with | Mechanism / direction | Severity | Action |
|---|---|---|---|---|
| Vitamin D | Thiazide diuretics | Decreased urinary calcium excretion plus vitamin D can increase hypercalcemia risk. | Use caution | Medical monitoring of calcium and vitamin D status. NIH ODS |
| Vitamin D | Orlistat or fat-malabsorption states | Reduced absorption of vitamin D from food and supplements. | Monitor | Assess status and timing with clinician if supplementing. NIH ODS |
| Vitamin D | Systemic corticosteroids | Reduced calcium absorption and impaired vitamin D metabolism. | Monitor | Discuss bone/mineral plan if repeated or chronic systemic steroids are used. NIH ODS |
| Vitamin D | Atorvastatin, lovastatin, simvastatin | High supplemental vitamin D may reduce statin potency through shared metabolism. | Monitor | Avoid high-dose self-supplementation. NIH ODS |
| Omega-3 EPA/DHA | Warfarin and similar anticoagulants | Antiplatelet effects can prolong clotting time at high doses; INR monitoring may be needed. | Monitor | Discuss before high-dose use or surgery. NIH ODS |
| Omega-3 EPA/DHA | Aspirin, clopidogrel, DOACs, NSAID-heavy use | Potential platelet effects warrant medication review, but ODS does not establish a clinically important interaction with every listed drug; most summarized studies did not find clinically significant bleeding. | Use caution | Review the exact product, dose and medicine with the care team; do not infer a demonstrated class-wide interaction. NIH ODS |
| Omega-3 EPA/DHA | Atrial fibrillation risk context | High-dose 4 g/day trials found slightly increased atrial fibrillation risk in high-risk groups. | Use caution | Do not self-prescribe high-dose omega-3. NIH ODS |
| Probiotics | Immunosuppressants, chemotherapy, transplant medicines, biologics, severe illness | This is a vulnerable-host safety concern, not a proven pharmacokinetic interaction: live microorganisms can cause infection in severely ill or immunocompromised people. | Avoid unless supervised | Clinician approval required in high-risk groups. NCCIH |
| Probiotics | Antibiotics | Antibiotics may kill probiotic organisms; probiotic may alter GI effects. | Timing issue | Ask clinician/pharmacist about timing and whether use is appropriate. |
| Evening primrose oil | Warfarin/anticoagulants; surgery | Possible increased bleeding risk. | Use caution | Avoid or medically supervise. Cochrane |
| Homeopathic products | Any medication if product contains active ingredients | Some products labeled homeopathic may contain substantial active ingredients and cause interactions. | Use caution | Do not assume “diluted” means interaction-free. NCCIH |
| Essential oils | Irritated skin or simultaneous topical-product use | Tea tree oil can cause redness or irritation; a specific interaction with prescribed topical eczema medicines has not been established by the cited page. | Use caution | Avoid on active eczema unless clinician-directed. NCCIH |
| Detoxes / cleanses | Diabetes, chronic illness, or regular medicine use | NCCIH documents fasting, dehydration, diarrhea, nutrient loss and electrolyte risks; it does not verify each specific drug interaction previously listed. | Avoid unsupervised | People with diabetes should consult their care team before major dietary changes; cleanses are not evidence-based eczema treatment. NCCIH |
| Black seed oil | Anticoagulants, antihypertensives, antidiabetics, sedatives, immunomodulators | Human interaction evidence for eczema use is insufficient; theoretical and non-eczema pharmacology concerns exist. | Data gap | Treat the interaction data gap as a safety limitation, not proof of safety. |
Text version of this infographic
- Check bleeding risk before omega-3 or evening primrose oil, especially with anticoagulants or antiplatelets.
- Check calcium/kidney risk before vitamin D, especially with thiazides or kidney disease.
- Check immune risk before probiotics in severe illness or immunosuppression.
- Avoid essential oils on open or inflamed eczema because irritation and allergic contact dermatitis can worsen symptoms.
- Avoid detoxes with chronic disease or medicines because fasting, diarrhea, dehydration, and electrolyte shifts can alter medication effects.
Who should avoid eczema supplements
Avoid unsupervised eczema supplementation in infants, pregnancy/lactation, immunocompromised people, people with kidney disease, people taking anticoagulants or antiplatelets, people with atrial fibrillation risk, people using systemic immunosuppressants, and people with severe or infected eczema. These groups map directly to known safety cautions for probiotics, vitamin D, omega-3, evening primrose oil, detoxes, and topical essential oils (NCCIH probiotics, NIH ODS vitamin D, NIH ODS omega-3, NCCIH detoxes).
Do not replace moisturizers, topical anti-inflammatory medicines, infection evaluation, or allergy/patch testing with supplements. AAD emphasizes that eczema relief usually requires an eczema-friendly skin care plan, trigger avoidance, and medication when needed, and the AAD guideline strongly recommends moisturizers and topical anti-inflammatory options for atopic dermatitis management (AAD food guidance, AAD guideline).
Text version of this infographic
- First ask whether barrier care is optimized: daily moisturizer, trigger control, and appropriate flare medicine.
- If not, fix the core plan before adding supplements.
- If yes, ask whether there is a targeted reason, such as low vitamin D status or low EPA/DHA intake.
- Screen for medication and condition risks: bleeding, calcium, immune, and kidney risks.
- If trying a supplement, trial one ingredient only and track itch, sleep, flares, and side effects.
Independent evidence, funding, and conflict review
Research funding at a glance
6 disclosure entries. The counts below summarize independence tiers explicitly assigned in this article. They count disclosures, not studies, funding amounts or evidence quality.
Consult this article’s source and funding notes for named funders, countries, relationships and exceptions where available. Institutional backing, researcher interests and trial sponsorship are separate questions. Public funding alone does not establish independence; commercial ties alone do not prove a claim false. This overview is not a new financial audit.
| Source | Money trail clarity | Method quality | Incentive risk | Overall credibility | Likely motivation |
|---|---|---|---|---|---|
| Cochrane EPO/borage review | Review listed internal support and no external support; an author disclosed Efamol cash and material support for an included trial. | Systematic review of 27 trials; small samples and missing data limit certainty. | Company-supported trial/author tie was disclosed; another reviewer assessed the author’s own trial. | Useful systematic review; financing and methods still require context. | Likely academic evidence-synthesis role; personal motivation was not independently established. |
| Cochrane probiotics review | Public/institutional review support plus declared author industry ties; 10 supplier-funded trials and 4 with unreported funding. | 39 RCTs; moderate-certainty patient-rated symptoms and low-certainty other outcomes, with heterogeneity. | Negative conclusions do not erase declared Danone/Nutricia/Nestlé, Prota or pharmaceutical relationships. | Useful synthesis; conclusions and financing should be assessed separately. | Academic evidence-synthesis role; personal motivation was not independently established. |
| 2024 vitamin D meta-analysis | 4/5: no external funding; author conflicts disclosed. | 4/5: RCT meta-analysis, heterogeneity present. | 2/5: author pharma relationships in dermatology. | Moderate. | Academic publication and disease-treatment synthesis; interpret cautiously. |
| EPA pediatric RCT | No specific grant or financial conflicts declared; named commercial EPA product and placebo manufacture, with purchase/donation terms unreported. | Randomized/blinded but small and four weeks; conflicting abstract/table SCORAD figures. | Product-support terms unknown; no reported financial conflict is not proof of complete independence. | Preliminary evidence with reporting and procurement limitations. | Academic trial role; personal motivation was not independently established. |
| Omega-3/GLA/vitamin D combination RCT | 5/5: sponsor disclosed. | 4/5: randomized triple-blind design. | 2/5: product-company funding and multi-ingredient attribution problem. | Moderate-low for ingredient-specific claims. | Test sponsor-supported product; useful but not independent enough for strong claims. |
| NCCIH detox safety page | 4/5: public-health source, no product endorsement. | 4/5: summarizes evidence and safety. | 5/5: no direct product upside. | Strong for safety and “no compelling evidence” claim. | Public education and harm reduction. |
Frequently Asked Questions
What is the best supplement for eczema?
There is no best universal eczema supplement. Vitamin D results are mixed, and correcting deficiency is a separate nutritional indication. EPA/DHA trials are small and have reporting or sponsorship limits. Routine probiotics are not supported, and preliminary adult findings do not establish a proven strain or product (2024 vitamin D meta-analysis, EPA RCT, Cochrane probiotics review).
Can vitamin D cure eczema?
No. Vitamin D may modestly reduce eczema severity in some studies, but meta-analyses conflict and vitamin D toxicity can be serious when people self-prescribe high doses (2024 vitamin D meta-analysis, NIH ODS vitamin D).
Do omega-3 supplements help eczema?
Possibly for some people, but the evidence is not strong enough for a routine recommendation. A small EPA trial in children reported benefit, but its SCORAD figures conflict and capsule purchase/donation terms were not reported, while the older 2012 Cochrane supplement review found no convincing evidence for dietary supplements overall and described fish-oil evidence as small-study and modest (EPA RCT, Cochrane dietary supplements review).
Are probiotics good for eczema?
Routine probiotic treatment is not evidence-based for established eczema. Cochrane found probiotics probably make little or no difference in patient-rated symptoms, although NCCIH notes preliminary adult strain-specific evidence and mixed prevention signals (Cochrane probiotics review, NCCIH probiotics).
Does evening primrose oil work for eczema?
No reliable evidence supports it. Cochrane reviewed 27 studies with 1,596 participants and found no statistically significant advantage for evening primrose oil or borage oil over placebo (Cochrane evening primrose/borage review).
Is black seed oil proven for eczema?
No. A 2022 review found small heterogeneous skin-disease studies and noted major limitations, including lack of standardization, limited sample size, no PROSPERO preregistration, and broad pooling across skin disorders (Nigella sativa review).
Are essential oils safe for eczema?
Essential oils can irritate or sensitize eczema-prone skin, and tea tree oil should not be swallowed because oral use can cause serious neurologic symptoms such as confusion, unsteadiness, inability to walk, and coma. They should not be used on active eczema as a default treatment (NCCIH tea tree oil).
Can detoxes or cleanses clear eczema?
No credible evidence shows detoxes clear eczema or remove a defined eczema-causing toxin. NCCIH reports no compelling evidence for detox diets eliminating toxins and notes risks such as dehydration, electrolyte imbalance, diarrhea, fainting, and malabsorption (NCCIH detoxes and cleanses).
Sources
- Cochrane. Dietary supplements for established atopic eczema in adults and children. https://www.cochrane.org/evidence/CD005205_dietary-supplements-established-atopic-eczema-adults-and-children
- Cochrane. Probiotics for treating eczema. https://www.cochrane.org/evidence/CD006135_probiotics-treating-eczema
- Cochrane. Oral evening primrose oil and borage oil for eczema. https://www.cochrane.org/evidence/CD004416_oral-evening-primrose-oil-and-borage-oil-eczema
- American Academy of Dermatology. Atopic dermatitis clinical guideline. https://www.aad.org/member/clinical-quality/guidelines/atopic-dermatitis
- American Academy of Dermatology. Can food fix eczema? https://www.aad.org/public/diseases/eczema/childhood/treating/food-fix
- Nielsen AY, Høj S, Thomsen SF, Meteran H. Vitamin D supplementation for treating atopic dermatitis. https://pmc.ncbi.nlm.nih.gov/articles/PMC11644640/
- Park JS, et al. Effect of vitamin D on the treatment of atopic dermatitis with consideration of heterogeneities. https://pmc.ncbi.nlm.nih.gov/articles/PMC10079516/
- Mirrahimi B, et al. Evaluating the effect of eicosapentaenoic acid in children with atopic dermatitis. https://pmc.ncbi.nlm.nih.gov/articles/PMC9901318/
- Niseteo T, et al. Effect of omega-3 polyunsaturated fatty acid supplementation on clinical outcome of atopic dermatitis in children. https://pmc.ncbi.nlm.nih.gov/articles/PMC11397185/
- NIH Office of Dietary Supplements. Vitamin D fact sheet for health professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
- NIH Office of Dietary Supplements. Omega-3 fatty acids fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- NCCIH. Probiotics: usefulness and safety. https://www.nccih.nih.gov/health/probiotics-usefulness-and-safety
- NCCIH. Evening primrose oil: usefulness and safety. https://www.nccih.nih.gov/health/evening-primrose-oil
- NCCIH. Homeopathy. https://www.nccih.nih.gov/health/homeopathy
- Ernst E. Homeopathy for eczema: a systematic review of controlled clinical trials. PubMed. https://pubmed.ncbi.nlm.nih.gov/22568455/
- NCCIH. Tea tree oil: usefulness and safety. https://www.nccih.nih.gov/health/tea-tree-oil
- NCCIH. Detoxes and cleanses: what you need to know. https://www.nccih.nih.gov/health/detoxes-and-cleanses-what-you-need-to-know
- Nasiri N, et al. The therapeutic effects of Nigella sativa on skin disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC9744621/
Have a question — or want us to cover something?
Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.
One daily research roundup
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.